Submission
CHPA comments on proposed recommendations for the reauthorization of the Prescription Drug User Fee Act.
Oct 31, 2011
While the monograph system has served our nation well, it has become cumbersome and outdated and needs to be modernized.
Jun 14, 2016
CHPA appreciates the opportunity to provide comments on the FDA’s draft guidance for industry entitled “Formal Meetings Between the Food and Drug Administration and Sponsors or Applicants of Prescription Drug User Fee Act Products”.
Jun 3, 2015
